INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 149 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,044,785 | -53.2% | 56,353 | -66.1% | 0.01% | -54.5% |
Q1 2023 | $2,233,772 | -33.2% | 166,327 | -38.5% | 0.01% | -42.1% |
Q4 2022 | $3,345,355 | -28.1% | 270,441 | -19.0% | 0.02% | -24.0% |
Q3 2022 | $4,656,000 | +7.9% | 333,729 | +6.8% | 0.02% | +13.6% |
Q2 2022 | $4,315,000 | -12.0% | 312,476 | +3.7% | 0.02% | -21.4% |
Q1 2022 | $4,901,000 | +27.5% | 301,213 | +27.6% | 0.03% | +33.3% |
Q4 2021 | $3,844,000 | -8.2% | 235,996 | -16.3% | 0.02% | -22.2% |
Q3 2021 | $4,189,000 | -35.1% | 282,062 | -12.7% | 0.03% | -40.0% |
Q2 2021 | $6,455,000 | -22.5% | 323,236 | -10.4% | 0.04% | -26.2% |
Q1 2021 | $8,325,000 | -9.2% | 360,685 | -2.9% | 0.06% | -20.8% |
Q4 2020 | $9,172,000 | -29.7% | 371,324 | +17.9% | 0.08% | -29.4% |
Q3 2020 | $13,053,000 | +692.1% | 314,839 | +815.2% | 0.11% | +473.7% |
Q2 2020 | $1,648,000 | -1.1% | 34,402 | +30.0% | 0.02% | -60.4% |
Q1 2020 | $1,667,000 | -51.6% | 26,472 | -4.8% | 0.05% | -28.4% |
Q4 2019 | $3,445,000 | +1431.1% | 27,801 | +720.1% | 0.07% | +1575.0% |
Q3 2019 | $225,000 | -63.9% | 3,390 | -39.2% | 0.00% | -78.9% |
Q1 2019 | $624,000 | -43.1% | 5,574 | -48.7% | 0.02% | -62.0% |
Q4 2018 | $1,096,000 | +14.3% | 10,875 | -33.8% | 0.05% | +138.1% |
Q4 2017 | $959,000 | +101.9% | 16,424 | +100.5% | 0.02% | +90.9% |
Q3 2017 | $475,000 | – | 8,191 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 234,375 | $23,623,000 | 22.67% |
Boxer Capital, LLC | 600,000 | $60,474,000 | 7.47% |
DLD Asset Management, LP | 834,600 | $84,136,000 | 5.77% |
GREAT POINT PARTNERS LLC | 200,000 | $20,158,000 | 2.55% |
BB BIOTECH AG | 575,719 | $58,027,000 | 1.86% |
Elk Creek Partners, LLC | 207,657 | $20,930,000 | 1.74% |
ALTRINSIC GLOBAL ADVISORS LLC | 277,944 | $28,014,000 | 1.34% |
Sarissa Capital Management LP | 54,000 | $5,442,000 | 1.21% |
QCM Cayman, Ltd. | 2,181 | $220,000 | 0.90% |
Opus Point Partners Management, LLC | 3,534 | $356,000 | 0.78% |